Terms: = Sarcomas AND XPO1, DKFZp686B1823, 7514, ENSG00000082898, O14980, CRM1 AND Prognosis
3 results:
1. Circ-xpo1 upregulates xpo1 expression by sponging multiple miRNAs to facilitate osteosarcoma cell progression.
Jiang Y; Hou J; Zhang X; Xu G; Wang Y; Shen L; Wu Y; Li Y; Yao L
Exp Mol Pathol; 2020 Dec; 117():104553. PubMed ID: 33091396
[TBL] [Abstract] [Full Text] [Related]
2. Selinexor, a Selective Inhibitor of Nuclear Export (SINE) compound, acts through NF-κB deactivation and combines with proteasome inhibitors to synergistically induce tumor cell death.
Kashyap T; Argueta C; Aboukameel A; Unger TJ; Klebanov B; Mohammad RM; Muqbil I; Azmi AS; Drolen C; Senapedis W; Lee M; Kauffman M; Shacham S; Landesman Y
Oncotarget; 2016 Nov; 7(48):78883-78895. PubMed ID: 27713151
[TBL] [Abstract] [Full Text] [Related]
3. The expression of crm1 is associated with prognosis in human osteosarcoma.
Yao Y; Dong Y; Lin F; Zhao H; Shen Z; Chen P; Sun YJ; Tang LN; Zheng SE
Oncol Rep; 2009 Jan; 21(1):229-35. PubMed ID: 19082467
[TBL] [Abstract] [Full Text] [Related]
